IL2 and acute myeloid leukemia: Not only are NK cells able to treat solid tumors, but they also play a key role in immunotherapies against hematological cancer like acute myeloid leukemia (AML), by using high doses of these cells [115] or infusing NK cells after chemotherapy along with IL-2 (NCT02763475).